合成方法和临床批准的小分子抗艾滋病毒药物的应用:最新情况
1Zhongshan Hospital Affiliated to Dalian University, Dalian, 116001, China.
European journal of medicinal chemistry
|October 6, 2023
概括
小分子药物改变了艾滋病的治疗方法,减少了死亡和医疗费用. 然而,抗药性和毒性等挑战需要持续研究新的艾滋病毒治疗方法.
科学领域:
- 药理学和病毒学.
- 药用化学 医学化学
背景情况:
- 化疗剂显著改善了艾滋病毒/艾滋病的管理,降低了发病率,死亡率和医疗保健成本.
- 挑战仍然存在,包括治疗疗效的变化,耐药性HIV菌株的出现以及潜在的药物毒性.
研究的目的:
- 审查临床批准的小分子药物用于艾滋病毒/艾滋病治疗.
- 分析药物类别,应用,合成,作用机制和组合疗法.
- 探索新型抗艾滋病毒药物开发的未来方向.
主要方法:
- 临床批准的小分子药物对艾滋病毒/艾滋病的文献综述.
- 对主要药物类别的分析:NRTI,NNRTI,PI,整合酶抑制剂,进入抑制剂和药理动力增强剂.
- 检查药物应用,合成途径,作用机制和联合抗逆转录病毒疗法.
主要成果:
- 小分子药物彻底改变了艾滋病毒/艾滋病的治疗方法,导致疾病进展和死亡率大幅下降.
- 尽管取得了成功,但病毒耐药性和药物毒性等挑战需要持续的治疗创新.
- 该审查详细介绍了各种药物类别及其在当前和未来艾滋病毒/艾滋病管理中的作用.
结论:
- 小分子药物对于治疗艾滋病毒/艾滋病至关重要,但局限性需要开发新的治疗策略.
- 了解药物机制和耐药性途径是推动艾滋病毒治疗的关键.
- 对新的药理学药剂和方法的持续研究对于对抗持续的HIV复制和改善患者的治疗结果至关重要.
相关概念视频
Retrovirus Life Cycles
46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K


